Pablo D Radusky1,2, Ines Aristegui3,4, Lissa N Mandell5, Emanuel Dell'Isola3, Virginia Zalazar3, Nadir Cardozo3,6, María L Alcaide7, Stephen M Weiss5, Deborah L Jones5, Omar Sued3. 1. Research Department, Fundación Huésped, Buenos Aires, Argentina. pablo.radusky@huesped.org.ar. 2. Faculty of Psychology, Universidad de Buenos Aires, Buenos Aires, Argentina. pablo.radusky@huesped.org.ar. 3. Research Department, Fundación Huésped, Buenos Aires, Argentina. 4. Department of Research in Psychology, Universidad de Palermo, Buenos Aires, Argentina. 5. Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA. 6. Association of Transvestites, Transsexuals, and Transgenders of Argentina (A.T.T.T.A.), Buenos Aires, Argentina. 7. Division of Infectious Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
Abstract
BACKGROUND: Transgender women (TGW) consistently show lower adherence to antiretroviral treatment (ART), than cisgender people (CP) living with HIV. This study examined sociodemographic and psychosocial factors associated with gender identity among individuals disengaged from HIV care in Argentina. METHODS: Data for this study was obtained at baseline from the Conexiones y Opciones Positivas en la Argentina 2 (COPA2) study. Forty-one TGW and 360 CP (177 male, 183 female) disengaged from HIV care completed questionnaires assessing sociodemographic information, severity of depressive symptoms, substance and alcohol use, patient-provider relationship quality, self-efficacy, ART adherence motivation, self-reported adherence, and treatment-related factors. Analyses included chi-square tests exploring the association between categorical variables and gender identity, and ANCOVAs comparing groups controlling for age. RESULTS: Being a TGW was associated with having only public health insurance; substance use, particularly cocaine; substance-related problems; and hazardous drinking. TGW showed more negative consequences related to substance use, more hazardous alcohol use, lower patient-provider relationship quality, and lower self-reported adherence, than CP. CONCLUSIONS: Harm reduction should be a key component in HIV care for TGW to address substance use. Health care teams should receive formal training in patient-provider communication skills and trans-specific competencies to enhance TGW's adherence and retention. Public policies to address structural factors that negatively affect TGW's adherence to ART are also needed.
BACKGROUND: Transgender women (TGW) consistently show lower adherence to antiretroviral treatment (ART), than cisgender people (CP) living with HIV. This study examined sociodemographic and psychosocial factors associated with gender identity among individuals disengaged from HIV care in Argentina. METHODS: Data for this study was obtained at baseline from the Conexiones y Opciones Positivas en la Argentina 2 (COPA2) study. Forty-one TGW and 360 CP (177 male, 183 female) disengaged from HIV care completed questionnaires assessing sociodemographic information, severity of depressive symptoms, substance and alcohol use, patient-provider relationship quality, self-efficacy, ART adherence motivation, self-reported adherence, and treatment-related factors. Analyses included chi-square tests exploring the association between categorical variables and gender identity, and ANCOVAs comparing groups controlling for age. RESULTS: Being a TGW was associated with having only public health insurance; substance use, particularly cocaine; substance-related problems; and hazardous drinking. TGW showed more negative consequences related to substance use, more hazardous alcohol use, lower patient-provider relationship quality, and lower self-reported adherence, than CP. CONCLUSIONS: Harm reduction should be a key component in HIV care for TGW to address substance use. Health care teams should receive formal training in patient-provider communication skills and trans-specific competencies to enhance TGW's adherence and retention. Public policies to address structural factors that negatively affect TGW's adherence to ART are also needed.
Authors: Walter Bockting; Caitlin MacCrate; Hayley Israel; Joanne E Mantell; Robert H Remien Journal: AIDS Patient Care STDS Date: 2019-12-17 Impact factor: 5.078
Authors: Deborah L Jones; Omar Sued; Diego Cecchini; Lina Bofill; Ryan Cook; Mar Lucas; Alejandra Bordato; Isabel Cassetti; Pedro Cahn; Stephen M Weiss Journal: AIDS Behav Date: 2016-05
Authors: Raquel B De Boni; Bryan E Shepherd; Beatriz Grinsztejn; Carina Cesar; Claudia Cortés; Denis Padgett; Eduardo Gotuzzo; Pablo F Belaunzarán-Zamudio; Peter F Rebeiro; Stephany N Duda; Catherine C McGowan Journal: AIDS Behav Date: 2016-11
Authors: Tonia Poteat; Andrea L Wirtz; Anita Radix; Annick Borquez; Alfonso Silva-Santisteban; Madeline B Deutsch; Sharful Islam Khan; Sam Winter; Don Operario Journal: Lancet Date: 2014-07-22 Impact factor: 79.321
Authors: Omar Sued; Isabel Cassetti; Diego Cecchini; Pedro Cahn; Lina Bofill de Murillo; Stephen M Weiss; Lissa N Mandell; Manasi Soni; Deborah L Jones Journal: Trials Date: 2018-07-24 Impact factor: 2.279
Authors: Hanalise V Huff; Paloma M Carcamo; Monica M Diaz; Jamie L Conklin; Justina Salvatierra; Rocio Aponte; Patricia J Garcia Journal: Int J Environ Res Public Health Date: 2022-06-12 Impact factor: 4.614